Anthracycline-free neoadjuvant therapy with nab-paclitaxel and carboplatin in nonluminal breast cancer: a single-arm phase II trial

被引：0
|
作者：
Liu, Deyue
Zhu, Li
Wu, Jiayi
Wang, Wei
Ding, Shuning
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-18-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-18-09
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial
    Chen, Li
    Jiang, Yi-Zhou
    Wu, Song-Yang
    Wu, Jiong
    Di, Gen -Hong
    Liu, Guang-Yu
    Yu, Ke-Da
    Fan, Lei
    Li, Jun-Jie
    Hou, Yi-Feng
    Hu, Zhen
    Chen, Can-Ming
    Huang, Xiao-Yan
    Cao, A-Yong
    Hu, Xin
    Zhao, Shen
    Ma, Xiao-Yan
    Xu, Ying
    Sun, Xiang-Jie
    Chai, Wen -Jun
    Guo, Xiaomao
    Chen, Xizi
    Xu, Yanhui
    Zhu, Xiao-Yu
    Zou, Jian-Jun
    Yang, Wen-Tao
    Wang, Zhong-Hua
    Shao, Zhi-Ming
    CLINICAL CANCER RESEARCH, 2022, 28 (13) : 2807 - 2817
  • [42] Gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer: A multicenter, single-arm, phase I/II trial
    Pressiani, T.
    Balsano, R.
    Giordano, L.
    Milella, M.
    Bergamo, F.
    Bozzarelli, S.
    Noventa, S.
    Ferrari, D.
    Scartozzi, M.
    Parra, H. J. Soto
    Auriemma, A.
    Solda, C.
    Zaniboni, A.
    Zecchetto, C.
    Rizzato, M. D.
    Rimassa, L.
    Santoro, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S120 - S120
  • [43] A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer
    Yam, Clinton
    Mittendorf, Elizabeth A.
    Garber, Haven R.
    Sun, Ryan
    Damodaran, Senthil
    Murthy, Rashmi K.
    Ramirez, David
    Karuturi, Meghan
    Layman, Rachel M.
    Ibrahim, Nuhad
    Rauch, Gaiane M.
    Adrada, Beatriz E.
    Candelaria, Rosalind P.
    White, Jason B.
    Ravenberg, Elizabeth
    Clayborn, Alyson
    Ding, Qing Qing
    Symmans, W. Fraser
    Prabhakaran, Sabitha
    Thompson, Alastair M.
    Valero, Vicente
    Tripathy, Debu
    Huo, Lei
    Moulder, Stacy L.
    Litton, Jennifer K.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 199 (03) : 457 - 469
  • [44] A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer
    Clinton Yam
    Elizabeth A. Mittendorf
    Haven R. Garber
    Ryan Sun
    Senthil Damodaran
    Rashmi K. Murthy
    David Ramirez
    Meghan Karuturi
    Rachel M. Layman
    Nuhad Ibrahim
    Gaiane M. Rauch
    Beatriz E. Adrada
    Rosalind P. Candelaria
    Jason B. White
    Elizabeth Ravenberg
    Alyson Clayborn
    Qing Qing Ding
    W. Fraser Symmans
    Sabitha Prabhakaran
    Alastair M. Thompson
    Vicente Valero
    Debu Tripathy
    Lei Huo
    Stacy L. Moulder
    Jennifer K. Litton
    Breast Cancer Research and Treatment, 2023, 199 : 457 - 469
  • [45] Phase II Trial of Neoadjuvant Nab-Paclitaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy
    Shepard, D. R.
    Dreicer, R.
    Garcia, J.
    Elson, P.
    Magi-Galluzzi, C.
    Raghavan, D.
    Stephenson, A. J.
    Klein, E. A.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 1672 - 1677
  • [46] Biomarker Analyses from a Phase II Trial of Nab-Paclitaxel/Carboplatin vs Emcitabine/Carboplatin in Advanced Squamous Cell Lung Cancer
    Yang, Jin-Ji
    Ben, Xiao-Song
    Huang, Cheng
    Song, Yong
    Cheng, Ying
    Chen, Gongyan
    Yan, Hong-Hong
    Zhou, Qing
    Chen, Hua-Jun
    Zhang, Xu-Chao
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S656 - S656
  • [47] ASO Author Reflections: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma
    Shishir K. Maithel
    Annals of Surgical Oncology, 2023, 30 : 6567 - 6568
  • [48] Phase II Study of Neoadjuvant Weekly nab-Paclitaxel and Carboplatin, With Bevacizumab and Trastuzumab, As Treatment For Women With Locally Advanced HER2+ Breast Cancer
    Yardley, Denise A.
    Raefsky, Eric
    Castillo, Raul
    Lahiry, Anup
    LoCicero, Richard
    Thompson, Dana
    Shastry, Mythili
    Burris, Howard A., III
    Hainsworth, John D.
    CLINICAL BREAST CANCER, 2011, 11 (05) : 297 - 305
  • [49] ASO Visual Abstact: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma
    Maithel, Shishir K.
    Keilson, Jessica M.
    Cao, Hop S. Tran
    Rupji, Manali
    Mahipal, Amit
    Lin, Bruce S.
    Javle, Milind M.
    Cleary, Sean P.
    Akce, Mehmet
    Switchenko, Jeffrey M.
    Rocha, Flavio G.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (11) : 6569 - 6570
  • [50] ASO Visual Abstact: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma
    Shishir K. Maithel
    Jessica M. Keilson
    Hop S. Tran Cao
    Manali Rupji
    Amit Mahipal
    Bruce S. Lin
    Milind M. Javle
    Sean P. Cleary
    Mehmet Akce
    Jeffrey M. Switchenko
    Flavio G. Rocha
    Annals of Surgical Oncology, 2023, 30 : 6569 - 6570
12345